News Formal

FDA Panel Backs Innoviva's Drug for Multidrug-Resistant Bacterial Infections

  • 📰 Medscape
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 55%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

FDA panel backs Innoviva's drug for multidrug-resistant bacterial infections. MedTwitter FDA innoviva

- A panel of U.S. Food and Drug Administration advisers on Monday unanimously voted in favor of Innoviva Inc's experimental antibiotic in the treatment of serious bacterial infections, typically associated with hospitalizations, the company said.

The FDA panel voted 12-0 in favor of the drug as a potential treatment for serious infections caused by the bacteria, including multidrug-resistant strains. The health regulator, which usually follows the recommendations of its expert panel but is not obligated to do so, is expected to make its final decision by May 29 on the use of the drug.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 386. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

This US company has a robotic solution for solar panel constructionSarcos Robotics has developed a robot to construct large scale solar fields which it claims reduces costs and accelerates the construction of solar fields.
Source: IntEngineering - 🏆 287. / 63 Read more »